Fig. 3From: Optimization of the production process for the anticancer lead compound illudin M: downstream processingBinding capacity of XAD16N in batch operation. The blue scatter plot illustrates the percentage of illudin M bound to increasing concentrations of XAD16N using 10 mL of cell-free supernatant containing 293 mg L−1 of illudin MBack to article page